US Stock MarketDetailed Quotes

SRPT Sarepta Therapeutics

Watchlist
  • 107.950
  • -1.510-1.38%
Close Feb 14 16:00 ET
  • 108.300
  • +0.350+0.32%
Post 19:14 ET
10.31BMarket Cap70.10P/E (TTM)

Sarepta Therapeutics Key Stats

Sarepta Therapeutics Q4 2024 Estimates Date

Currency:USDFeb 26, 2025

Estimate YoY
Revenue
631.03M
+59.04%
EPS
1.88
+300.60%
Strong Buy

Feb 17, 2025

Sarepta Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 12 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 698.256M--
Feb 26, 20252024/Q4-- / 631.030M--
Nov 6, 20242024/Q3467.172M / 405.059M--
Aug 7, 20242024/Q2362.931M / 387.814M--
May 1, 20242024/Q1413.464M / 375.429M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 698.256M--
Feb 26, 20252024/Q4-- / 631.030M--
Nov 6, 20242024/Q3467.172M / 405.059M--
Aug 7, 20242024/Q2362.931M / 387.814M--
May 1, 20242024/Q1413.464M / 375.429M--

Unlock Free Earnings Estimates

Sarepta Therapeutics Earnings Reports

Read more

Trending Stocks

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More